Sign in
4

Changes in Ownership

TREACE MEDICAL CONCEPTS, INC. Filed Acc 0001193125-26-047313

Chief Innovation Officer acquired 16,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scanlan Sean F. · Chief Innovation Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-10 Exercise or conversion : show line 1 in the form +16,875 $1.05 $17,719 706,474 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-10 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −16,875 0 D
Loading xslF345X05/ownership.xml…